ArticleCancer chemotherapy and pharmacology2018

A phase I study to assess afatinib in combination with carboplatin or with carboplatin plus paclitaxel in patients with advanced solid tumors.

Mary E R O'Brien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.